European Helicobacter & Microbiota Study Group (EHMSG 2022)

Event Date: September 8, 2022
Location: SEC (Scottish Event Campus) Centre Glasgow, Scotland

Returning to the UK after 27 years, the EHMSG 2022 meeting promises to be scientifically inspiring, providing the latest developments from the Helicobacter and Microbiota field.

BIOHIT are excited to be exhibiting at the EHMSG this year on it’s return to the UK, we’ll be joined by technical experts from Genetic Analysis, who will be show casing the GA-Map Dysbiosis test. Book a meeting to secure your time with our Norwegian colleagues.


About BIOHIT HealthCare

BIOHIT HealthCare is a Finnish biotech company, headquartered in Helsinki, that specialises in the development, manufacture and distribution of kits and assays for the screening, diagnosis and monitoring of digestive diseases. Its core disease focus areas include stomach health and dyspepsia, reflux and acid dysregulation, Inflammatory Bowel Disease (IBD), functional gastrointestinal disorders (FGID), Irritable bowel syndrome (IBS), and gut microbiota dysbiosis. Innovating for Health www.biohithealthcare.co.uk

Recent Posts

Intravenous medication

All you need to know about PANTS

April 6, 2022

Iron deficiency anaemia and atrophic gastritis – unravelling the loop

February 15, 2022

Taking the serological pathway to endoscopy

September 27, 2021

Steps to a faster diagnosis of gastric cancer

August 17, 2021